Einhorn Andrew J.
Insider CIK 1560685 · EDGE Chief Financial Officer · OSMT Chief Financial Officer · PTHS Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PTHS Pelthos Therapeutics Inc. | A Award | 2025-12-23 | 2025-12-29 | 12,000 | — | $0 | 12,000 | SEC↗ |
| RVLP RVL Pharmaceuticals plc | F Tax w/h | 2022-01-24 | 2022-01-26 | 9,607 | $1.13 | $10.9K | 141,473 | SEC↗ |
| OSMT Osmotica Pharmaceuticals p | A Award deriv | 2021-11-04 | 2021-11-08 | 249,814 | — | $0 | 249,814 | SEC↗ |
| OSMT Osmotica Pharmaceuticals p | F Tax w/h | 2021-05-18 | 2021-05-20 | 6,467 | $3.12 | $20.2K | 151,080 | SEC↗ |
| OSMT Osmotica Pharmaceuticals p | F Tax w/h | 2021-01-24 | 2021-01-26 | 9,668 | $4.46 | $43.1K | 157,547 | SEC↗ |
| OSMT Osmotica Pharmaceuticals p | A Award deriv | 2020-05-18 | 2020-05-20 | 71,550 | — | $0 | 71,550 | SEC↗ |
| OSMT Osmotica Pharmaceuticals p | A Award | 2020-05-18 | 2020-05-20 | 71,550 | — | $0 | 167,215 | SEC↗ |
| OSMT Osmotica Pharmaceuticals p | F Tax w/h | 2020-01-28 | 2020-01-30 | 9,184 | $7.00 | $64.3K | 95,665 | SEC↗ |
| OSMT Osmotica Pharmaceuticals p | A Award | 2019-01-24 | 2019-01-28 | 104,849 | — | $0 | 104,849 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | X Exercise deriv | 2017-03-01 | 2017-03-13 | 1,567 | — | $0 | 0 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | X Exercise | 2017-03-01 | 2017-03-13 | 1,567 | $2.39 | $3.7K | 43,223 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | A Award deriv | 2016-02-16 | 2016-02-18 | 50,000 | — | $0 | 50,000 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | C Conversion deriv | 2015-10-06 | 2015-10-08 | 14,286 | — | $0 | 0 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | C Conversion deriv | 2015-10-06 | 2015-10-08 | 21,506 | — | $0 | 0 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | C Conversion deriv | 2015-10-06 | 2015-10-08 | 32,956 | — | $0 | 0 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | C Conversion deriv | 2015-10-06 | 2015-10-08 | 6,494 | — | $0 | 0 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | C Conversion deriv | 2015-10-06 | 2015-10-08 | 29,032 | — | $0 | 0 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | C Conversion | 2015-10-06 | 2015-10-08 | 24,089 | — | $0 | 39,279 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | C Conversion | 2015-10-06 | 2015-10-08 | 4,747 | — | $0 | 15,190 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | C Conversion | 2015-10-06 | 2015-10-08 | 10,443 | — | $0 | 10,443 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | J Other | 2015-10-06 | 2015-10-08 | 2,377 | $6.79 | $16.1K | 41,656 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | J Other | 2015-10-06 | 2015-10-08 | 1,651 | $7.75 | $12.8K | 83,592 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | P Buy | 2015-10-06 | 2015-10-08 | 45,000 | $11.00 | $495.0K | 81,941 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | C Conversion | 2015-10-06 | 2015-10-08 | 21,221 | — | $0 | 36,941 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | C Conversion | 2015-10-06 | 2015-10-08 | 15,720 | — | $0 | 15,720 | SEC↗ |